AAAAAA

   
Results: 1-8 |
Results: 8
Patterns of prescription and drug use in ophthalmology in a tertiary hospital in Delhi
Authors: Biswas, NR Jindal, S Siddiquei, MM Maini, R
Citation: Nr. Biswas et al., Patterns of prescription and drug use in ophthalmology in a tertiary hospital in Delhi, BR J CL PH, 51(3), 2001, pp. 267-269
Analysis of cytokine expression in rheumatoid synovium has provided new insights into the pathogenesis of rheumatoid arthritis and new therapeutic opportunities
Authors: Feldmann, M Brennan, F Bondeson, J Paleolog, E Foxwell, B Maini, R
Citation: M. Feldmann et al., Analysis of cytokine expression in rheumatoid synovium has provided new insights into the pathogenesis of rheumatoid arthritis and new therapeutic opportunities, TRANSPLAN P, 33(3), 2001, pp. 2085-2086
A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomy
Authors: Maini, R Sullivan, L Snibson, GR Taylor, HR Loughnan, MS
Citation: R. Maini et al., A comparison of different depth ablations in the treatment of painful bullous keratopathy with phototherapeutic keratectomy, BR J OPHTH, 85(8), 2001, pp. 912-915
Correction of refractive error in the Victorian population: the feasibility of "off the shelf" spectacles
Authors: Maini, R Keeffe, J Weih, LA McCarty, CA Taylor, HR
Citation: R. Maini et al., Correction of refractive error in the Victorian population: the feasibility of "off the shelf" spectacles, BR J OPHTH, 85(11), 2001, pp. 1283-1286
Dipetalonema reconditum in the human eye
Authors: Huynh, T Thean, J Maini, R
Citation: T. Huynh et al., Dipetalonema reconditum in the human eye, BR J OPHTH, 85(11), 2001, pp. 1391-1392
Proposal to establish a register for the long term surveillance of adverseevents in patients with rheumatic diseases exposed to biological agents: the EULAR Surveillance Register for Biological Compounds
Authors: Silman, A Klareskog, L Breedveld, F Bresnihan, B Maini, R van Riel, P Symmons, D
Citation: A. Silman et al., Proposal to establish a register for the long term surveillance of adverseevents in patients with rheumatic diseases exposed to biological agents: the EULAR Surveillance Register for Biological Compounds, ANN RHEUM D, 59(6), 2000, pp. 419-420
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
Authors: Maini, R St Clair, EW Breedveld, F Furst, D Kalden, J Weisman, M Smolen, J Emery, P Harriman, G Feldmann, M Lipsky, P
Citation: R. Maini et al., Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial, LANCET, 354(9194), 1999, pp. 1932-1939
Uveitis associated with parvovirus infection
Authors: Maini, R Edelsten, C
Citation: R. Maini et C. Edelsten, Uveitis associated with parvovirus infection, BR J OPHTH, 83(12), 1999, pp. 1403-1404
Risultati: 1-8 |